Tamil Nadu focus

A BD-ready slice of the bulletin.

All headlines

Showing 121–140 of 140

Policy & Manufacturing
· Source: dtnext.in

Tamil Nadu’s 1st Biosimilar insulin facility in Chennai

Regenix Drugs has commissioned Tamil Nadu’s first biosimilar insulin facility in Chennai, producing Sustaglar, a long-acting glargine insulin. As only the fifth such unit in India, the plant will enhance access to affo...

Working a Tamil Nadu mandate?

Talk to Bucephalus